| |
| |
|
| Insider
Information: |
Posner Brian S |
| Relationship: |
Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
158,715 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$14,546,008 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
158,715 |
|
|
| Total
Value |
$14,546,008 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
4
|
1
|
|
Stock
price went up :
|
4
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
4.0
|
1.0
|
| Percentage
Gain/Loss : |
 41.0%
|
19.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
LMP Capital & Income Fund Inc |
SCD |
Officer of the Adviser |
2006-10-11 |
5,000 |
2006-10-11 |
0 |
Premium* |
|
|
Biogen Idec Inc |
BIIB |
Director |
2021-07-01 |
8,175 |
2009-06-03 |
0 |
Premium* |
|
|
Arch Capital Group Ltd |
ACGL |
|
2024-05-09 |
125,540 |
2011-11-04 |
0 |
Premium* |
|
|
Bg Medicine, Inc. |
BGMD |
Director |
2012-11-19 |
20,000 |
2012-05-22 |
0 |
Premium* |
|
|
Bioverativ Inc. |
BIVV |
Director |
2018-03-08 |
0 |
2017-04-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
72 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SCD |
LMP Capital & Income Fund... |
Officer of the Adviser |
• – – |
2006-10-11 |
4 |
B |
$17.95 |
$89,750 |
D/D |
5,000 |
5,000 |
2.74 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
– • – |
2008-07-23 |
4 |
A |
$0.00 |
$0 |
D/D |
1,750 |
1,750 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
– • – |
2009-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,245 |
3,995 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
– • – |
2010-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
5,735 |
9,730 |
0 |
- |
|
| ACGL |
Arch Capital Group Ltd |
Director |
– • – |
2011-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
1,326 |
1,658 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
– • – |
2011-05-25 |
4 |
OE |
$53.43 |
$1,746,844 |
D/D |
25,975 |
35,705 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
– • – |
2011-05-25 |
4 |
AS |
$93.74 |
$2,444,027 |
D/D |
(25,975) |
9,730 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
– • – |
2011-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,900 |
12,630 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
– • – |
2011-08-29 |
4 |
AS |
$92.53 |
$1,387,895 |
D/D |
(15,000) |
12,630 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
– • – |
2011-08-29 |
4 |
OE |
$71.38 |
$1,070,700 |
D/D |
15,000 |
27,630 |
0 |
- |
|
| ACGL |
Arch Capital Group Ltd |
Director |
– • – |
2011-11-04 |
4 |
A |
$0.00 |
$0 |
D/D |
332 |
332 |
0 |
- |
|
| ACGL |
Arch Capital Group Ltd |
Director |
– • – |
2012-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
3,888 |
8,862 |
0 |
- |
|
| BGMD |
Bg Medicine, Inc. |
Director |
– • – |
2012-05-22 |
4 |
B |
$4.04 |
$40,400 |
D/D |
10,000 |
10,000 |
2.39 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
– • – |
2012-06-04 |
4 |
OE |
$71.38 |
$171,312 |
D/D |
2,400 |
15,030 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
– • – |
2012-06-04 |
4 |
AS |
$126.45 |
$303,480 |
D/D |
(2,400) |
12,630 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
– • – |
2012-06-07 |
4 |
OE |
$71.38 |
$178,450 |
D/D |
2,500 |
15,130 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
– • – |
2012-06-07 |
4 |
AS |
$135.00 |
$337,500 |
D/D |
(2,500) |
12,630 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
– • – |
2012-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
2,020 |
14,650 |
0 |
- |
|
| BGMD |
Bg Medicine, Inc. |
Director |
– • – |
2012-11-19 |
4 |
B |
$1.17 |
$11,650 |
D/D |
10,000 |
20,000 |
2.39 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
• • – |
2013-03-18 |
4 |
AS |
$174.81 |
$786,645 |
D/D |
(4,500) |
10,150 |
0 |
- |
|
| ACGL |
Arch Capital Group Ltd |
Director |
– • – |
2013-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
2,802 |
11,664 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
• • – |
2013-06-11 |
4 |
AS |
$219.62 |
$443,632 |
D/D |
(2,020) |
8,130 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
• • – |
2013-06-12 |
4 |
A |
$0.00 |
$0 |
D/D |
1,305 |
9,435 |
0 |
- |
|
| ACGL |
Arch Capital Group Ltd |
Director |
– • – |
2013-08-02 |
4 |
B |
$25.25 |
$126,230 |
D/D |
5,000 |
5,000 |
2.39 |
- |
|
| ACGL |
Arch Capital Group Ltd |
Director |
– • – |
2013-08-19 |
4 |
B |
$23.58 |
$58,947 |
D/D |
2,500 |
7,500 |
2.39 |
- |
|
72 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
